WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells.
Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
June 28, 2024